Clinical trial
URO-BCG-4: Bladder Tumors Immunotherapy
NCT00213655 · University Hospital, Rouen, Other · Completed
Key facts
| NCT number | NCT00213655 |
|---|---|
| Title | URO-BCG-4 : Bladder Tumors Immunotherapy |
| Official title | Clinical Evaluation of Maintenance BCG Immunotherapy in Superficial Bladder Tumors |
| Lead sponsor | University Hospital, Rouen, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Bladder Cancer |
| Intervention type | Biological |
| Interventions | bladder tumor recurrence |
| Enrollment | 146 |
| Start date | Jun 1, 2004 |
| Primary completion | May 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 31, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: